A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- The Chainsmokers Actually Make a Great Nickelback Cover Band Mar 29, 2021
- Brazil registers 9,458 cases and 244 new deaths by Covid – ISTOÉ DINHEIRO Sep 19, 2021
- 6 reasons to quit smoking, according to the WHO May 31, 2021
- Experts Recommend Sleep Hygiene for Better Rest | Video May 27, 2021
- Vargas Llosa continued to write during his hospitalization for covid May 22, 2022
- “Important covid vaccine but don’t forget the other vaccinations” Jul 8, 2021
- Delta variant: Vaccinated twice against Corona and then fell ill – what could be the reason Jul 22, 2021